Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7154999 | 0.86 | CA2 (0.50) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL18817541 | 0.86 | CA2 (0.50) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL717188 | 0.86 | CA2 (0.45) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL1526302 | 0.84 | CA2 (0.46) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL4475938 | 0.84 | CA2 (0.46) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL1526299 | 0.84 | CA2 (0.46) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL589481 | 0.82 | — | — | |
| SCHEMBL4421192 | 0.82 | — | — | |
| SCHEMBL589285 | 0.82 | — | — | |
| SCHEMBL13130046 | 0.82 | CA2 (0.47) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324378-B2 | Prodrugs and conjugates of prenylation inhibitors | PURDUE RESEARCH FOUNDATION (US) | 2012-12-04 | — | — | US | disclosed |
| US-8268959-B2 | Suitable for binding high explosives, and may also be used as explosives in their own right; materials possess high energy density and are highly amenable to chemical modification thereby allowing for modification to the physical properties of the material; tacky and rubbery nature | THE SECRETARY OF STATE FOR DEFENSE (GB) | 2012-09-18 | — | — | US | disclosed |
| EP-2460842-A2 | Novel energetic polyphosphazenes | The Secretary of State For Defence (GB) | 2012-06-06 | — | — | EP | disclosed |
| US-20120053356-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | THE SECRETARY OF STATE FOR DEFENSE (GB) | 2012-03-01 | — | — | US | disclosed |
| US-20100249072-A1 | PRODRUGS AND CONJUGATES OF PRENYLATION INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2009029849-A1 | PRODRUGS AND CONJUGATES OF PRENYLATION INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2009-03-05 | — | — | WO | disclosed |
| EP-1960456-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2008-08-27 | — | — | EP | disclosed |
| US-20080108784-A1 | Suitable for binding high explosives, and may also be used as explosives in their own right; materials possess high energy density and are highly amenable to chemical modification thereby allowing for modification to the physical properties of the material; tacky and rubbery nature | DEFENSE, THE SECRETARY OF THE STATE FOR (GB) | 2008-05-08 | — | — | US | disclosed |
| WO-2006099313-A2 | PHOSPHATE CONJUGATES OF PRENYLATION INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006032882-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249072-A1 | PRODRUGS AND CONJUGATES OF PRENYLATION INHIBITORS | FNTA, FNTB, FDPS | CA2 1525/4885ALDH1A1 2414/4885NPSR1 3399/4885 |
| US-20120053356-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | ACLY, PEBP1, DDX42 | CA2 2462/4885ALDH1A1 4205/4885NPSR1 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.